Cargando…
Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer’s Disease
Prevention of dementia due to Alzheimer’s disease (d/AD) requires interventions that slow the disease process prior to symptom onset. To develop such interventions, one needs metrics that assess pre-symptomatic disease progression. Familiar measures of progression include cerebrospinal fluid (CSF) b...
Autores principales: | Tuwaig, Miranda, Savard, Mélissa, Jutras, Benoît, Poirier, Judes, Collins, D. Louis, Rosa-Neto, Pedro, Fontaine, David, Breitner, John C.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757649/ https://www.ncbi.nlm.nih.gov/pubmed/28984583 http://dx.doi.org/10.3233/JAD-170545 |
Ejemplares similares
-
Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer’s
Disease Pathogenesis
por: Meyer, Pierre-François, et al.
Publicado: (2018) -
INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
por: Meyer, Pierre-François, et al.
Publicado: (2019) -
Odor identification as a biomarker of preclinical AD in older adults at risk
por: Lafaille-Magnan, Marie-Elyse, et al.
Publicado: (2017) -
No apparent effect of naproxen on CSF markers of innate immune activation
por: Meyer, Pierre‐François, et al.
Publicado: (2019) -
Selective familiarity deficits in otherwise cognitively intact aging individuals with genetic risk for Alzheimer's disease
por: Schoemaker, Dorothee, et al.
Publicado: (2015)